Oct 10, 2025 06:03AM
Sep 4, 2025 06:13AM
Mar 3, 2025 06:15AM
Jan 27, 2025 11:47AM
Jan 17, 2025 06:39AM
Sep 30, 2024 07:00AM
Sep 17, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on Akero Therapeutics (AKRO)
Oct 17, 2023 04:05PM
Nov 4, 2022 07:00AM
Nov 4, 2022 07:00AM
Oct 11, 2022 04:01PM
Oct 11, 2022 04:01PM
Sep 19, 2022 04:01PM
Sep 19, 2022 04:01PM Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Sep 15, 2022 05:50AM
Sep 14, 2022 08:07PM
Sep 14, 2022 08:07PM
Sep 13, 2022 04:01PM
Sep 13, 2022 04:01PM
Sep 13, 2022 04:01PM
May 2, 2022 07:30AM Akero Therapeutics to Present at Upcoming Healthcare Conferences in May
May 2, 2022 07:30AM
Feb 28, 2022 06:21AM
Nov 15, 2021 06:14AM
Oct 5, 2021 08:00AM
Feb 23, 2021 04:05PM
Sep 28, 2020 04:05PM
Jul 1, 2020 07:01AM Akero Therapeutics (AKRO) PT Raised to $45 at H.C. Wainwright After Ph2a Results
Mar 2, 2020 07:05AM

21,311 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All